Curcumin exerts neuroprotective effects, in part, by modulating the aggregation of key pathological proteins implicated in neurodegenerative disorders, including amyloid-β (Aβ) in Alzheimer’s disease, α-synuclein in Parkinson’s disease, and Tau in tauopathies. Here, SNCA is linked to Parkinson disease.